Undervalued Small Caps With Insider Buying

Results

53

7 new

Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.

53 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	BOTJ	US$27.01	-2.6%	74.1%	US$123.0m	n/a	1.5	n/a	1.5%	Banks
	GABC	US$50.07	-1.7%	21.1%	US$1.9b	US$56.20	1.6	5.6%	2.5%	Banks
	UNB	US$23.71	-2.9%	-9.2%	US$118.7m	n/a	1.3	n/a	6.1%	Banks
	SHBI	US$23.23	-1.7%	39.0%	US$778.9m	US$25.75	1.3	8.1%	2.4%	Banks
	KINS	US$20.09	1.0%	47.8%	US$287.1m	US$24.00	8.2	14.6%	1.2%	Insurance
	ENOV	US$25.21	1.9%	-18.7%	US$1.5b	US$40.83	0.6	136.9%	n/a	Healthcare
	ORN	US$9.10	-7.2%	30.7%	US$375.4m	US$15.32	102.3	56.0%	n/a	Capital Goods
	BMRC	US$27.11	-3.7%	12.9%	US$430.4m	US$31.80	1.1	102.5%	3.7%	Banks
	HPP	US$14.71	6.6%	-21.3%	US$803.5m	US$17.00	0.3	62.0%	0%	Real Estate
	EMYB	US$22.30	-0.4%	32.0%	US$165.5m	n/a	1.3	n/a	2.5%	Banks
	TRIN	US$18.61	3.9%	17.9%	US$1.7b	US$18.50	12.5	20.8%	11.0%	Diversified Financials
	PFX New	US$54.41	17.9%	11.0%	US$98.9m	n/a	22.5	26.5%	2.6%	Diversified Financials
	ALRS	US$32.86	-1.9%	47.8%	US$816.1m	US$35.40	29.7	40.6%	2.7%	Diversified Financials
	FRST	US$16.30	-2.0%	47.4%	US$399.5m	US$19.19	0.9	-2.9%	2.5%	Banks
	ANIK	US$21.34	-0.6%	133.7%	US$291.5m	US$21.00	2.4	112.3%	n/a	Pharmaceuticals & Biotech
	ADTN New	US$7.71	-10.9%	-15.5%	US$631.1m	US$14.67	0.6	92.3%	0%	Tech
	HUN	US$9.60	-6.9%	-12.2%	US$1.7b	US$11.45	0.3	113.7%	3.6%	Materials
	UBCP New	US$15.48	1.3%	6.9%	US$92.9m	US$20.00	1.2	11.1%	6.2%	Banks
	CSR	US$54.60	-0.07%	-4.9%	US$953.8m	US$62.93	1.3	-147.0%	5.6%	Real Estate
	AZTA	US$32.88	-2.1%	6.9%	US$1.6b	US$35.25	2.3	110.0%	0%	Pharmaceuticals & Biotech
	ENBP	US$29.00	-0.5%	53.0%	US$166.9m	n/a	1.0	n/a	2.5%	Banks
	SUNS	US$7.61	-1.9%	-30.2%	US$103.4m	US$10.88	8.0	23.2%	15.8%	Diversified Financials
	CBKM	US$31.90	0.9%	57.5%	US$101.0m	n/a	1.1	n/a	2.6%	Banks
	THFF	US$79.61	-2.5%	37.4%	US$940.1m	US$84.00	1.4	5.7%	2.8%	Banks

Page 1 of 2